References
- Concia E, Bragantini D, Mazzaferri F. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. J Chemother. 2017;29(sup1):19–28.10.1080/1120009X.2017.1380397
- Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, et al. Epidemiologie, diagnostic, therapie, prevention und management unkompliziert, bakterieller, ambulant erworbener Harnwegs infektionen bei erwachsenen Patienten: Aktualisierung 2017 der interdisziplinären AWMF S3-Leitlinie. Der Urologe. 2017;56(6):746–58. German.
- Kranz J, Helbig S, Mandraka F, Schmidt S, Naber KG. The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship. Curr Opin Urol. 2017;27:127–32.10.1097/MOU.0000000000000365
- Wagenlehner FME, Münch F, Pilatz A, Bärmann B, Weidner W, Wagenlehner CM, et al. Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers. Antimicrob Agents Chemother. 2014;58(2):713–21.10.1128/AAC.02147-13
- Kresken M, Körber-Irrgang B. In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany. Antimicrob Agents Chemother. 2014;58(11):7019–20.10.1128/AAC.03946-14
- Sobke A, Makarewicz O, Baier M, Bär C, Pfister W, Gatermann SG, et al. Empiric treatment of lower urinary tract infections in the face of spreading multi-drug resistance: in vitro study of nitroxoline effectiveness. Int J Antimicrob Agents 2018;51(2):213–220.
- Pelletier C, Prognon P, Bourlioux P. Roles of divalent cations and pH in mechanism of actionof nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother. 1995;39(3):707–13.10.1128/AAC.39.3.707
- Latrache H, Bourlioux P, Karroua M, Zahir H, Hakkou A. Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Folia Microbiol (Praha). 2000;45(6):485–90.10.1007/BF02818714
- Sobke A, Klinger M, Hermann B, Sachse S, Nietzsche S, Makarewicz O, et al. The urinary antibiotic 5-nitro-8-hydroxyquinoline (nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrob Agents Chemother. 2012;56(11):6021–25.10.1128/AAC.01484-12
- Abouelhassan Y, Yang Q, Yousaf H, Nguyen MT, Rolfe M, Schultz GS, et al. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria. Int J Antimicrob Agents. 2017;49(2):247–51.10.1016/j.ijantimicag.2016.10.017
- Naber KG, Niggemann H, Stein G, Stein G. Review of the literature and individual patients’ meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections. BMC Infect Dis. 201414:628; [cited 2018 Jan 7]. Available from: http://www.biomedcentral.com/1471-2334/14/628.10.1186/s12879-014-0628-7
- Forstner C, Kwetkat A, Makarewicz O, Hartung A, Pfister W, Fünfstück R, et al. Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study. Clin Microbiol Infect 2017. Epub 2017 Sep 23. Available from: https://doi.org/10.1016/j.cmi.2017.11.007.
- The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. Available from: http://www.eucast.org.
- The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. Version 7.1, 2017. Available from: http://www.eucast.org.
- Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:490–5.
- Škerk V, Tambić Andrašević A, Sušić E. Amendments and updates to the ISKRA Croatian national guidelines for the treatment and prophylaxis of urinary tract infections in adults. Croatian J Infect. 2014;34(4):177–181.